Kuros Biosciences AG (ETR:YTSN)

Kuros Biosciences AG Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,037	859	138	54	61	61
Market Cap Growth	977.94%	523.03%	153.55%	-10.72%	-0.52%	20.93%
Enterprise Value	1,020	846	123	35	37	50
PS Ratio	12.88	10.66	3.82	2.99	4.57	16.40
PB Ratio	16.56	13.71	2.26	0.78	0.82	0.78
P/TBV Ratio	40.00	33.12	8.15	2.67	3.01	2.45
P/FCF Ratio	475.79	393.96	-	-	-	-
P/OCF Ratio	309.87	256.57	-	-	-	-
EV/Sales Ratio	12.64	10.50	3.41	1.90	2.77	13.27
EV/EBITDA Ratio	-	385.86	-	-	-	-
EV/EBIT Ratio	-	7414.24	-	-	-	-
EV/FCF Ratio	467.84	387.93	-	-	-	-
Debt / Equity Ratio	0.03	0.03	0.04	0.03	0.03	0.03
Debt / EBITDA Ratio	0.66	0.66	-	-	-	-
Debt / FCF Ratio	0.88	0.88	-	-	-	-
Asset Turnover	0.97	0.97	0.44	0.21	0.15	0.04
Inventory Turnover	1.18	1.18	1.27	1.47	2.33	1.96
Quick Ratio	1.64	1.64	2.22	2.20	2.72	7.69
Current Ratio	2.14	2.14	2.77	2.49	2.91	8.76
Return on Equity (ROE)	-6.44%	-6.44%	-16.18%	-20.02%	-9.33%	-14.18%
Return on Assets (ROA)	0.09%	0.09%	-4.12%	-7.06%	-5.90%	-8.09%
Return on Capital (ROIC)	0.11%	0.11%	-4.90%	-8.21%	-6.59%	-8.81%
Return on Capital Employed (ROCE)	0.20%	0.20%	-	-	-	-
Earnings Yield	-0.44%	-0.53%	-10.70%	-27.17%	-11.95%	-17.39%
FCF Yield	0.21%	0.25%	-7.14%	-14.41%	-9.13%	-14.04%
Buyback Yield / Dilution	-3.76%	-1.69%	-7.91%	-3.37%	-34.86%	-53.69%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.